Navigation Links
Amilpar Acquires ESHO
Date:2/1/2010

RIO DE JANEIRO, Feb. 1 /PRNewswire-FirstCall/ -- Amil Participacoes S.A. (Bovespa: AMIL3) ("Amilpar"), in accordance with CVM (the Brazilian Securities and Exchange Commission) Instruction 358/02, informs that today it exercised the option to purchase 100% of ESHO - Empresa de Servicos Hospitalares Ltda, as established in the Management and Hospital Call Option Agreement, signed on October 18, 2007, in the total amount of R$ 60.1 million, set after the auditing process, according to the decision taken by Amilpar's Board of Directors, in a meeting held on November 9, 2009.

The payment will be made in 48 monthly and successive installments, adjusted by the CDI (average interbank deposit rate in Brazil), the first installment with maturity on February 18 and the other installments on the 15th day of each month.

The main assets that comprise ESHO are the three hospitals which were already managed by Amilpar, as established in the Management and Hospital Call Option Agreement, and this acquisition is the accomplishment of the compromise made by Amilpar at the time of its IPO. Hospital information:

(i) CardioTrauma Hospital, located at Rua Farme de Amoedo, Ipanema, in the city and state of Rio de Janeiro, has 46 beds;

(ii) Mario Lioni Hospital, located at Rua Ana Neri, Bairro Vinte e Cinco de Agosto, Duque de Caxias, in the state of Rio de Janeiro, has 120 beds;

(iii) Hospital Paulistano, located at Rua Martiniano de Carvalho, the corner with Rua Pio XII, Bairro Liberdade, in the city and state of Sao Paulo, has 211 beds.

    To access the press release, visit our website at www.amilpar.com.br/ir.

    IR Contact
    Erwin Kleuser
    Investor Relations Officer
    Phone: +55 (21) 3805-1155
    invest@amil.com.br
    www.amilpar.com.br/ir

SOURCE Amil Participacoes S.A.

RELATED LINKS
http://www.amilpar.com.br/ir

'/>"/>

SOURCE Amil Participacoes S.A.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Amilpar - Relevant Fact - Public Offer Result
2. Amilpar - Press Release
3. Amilpar - Distribution of Interest on Capital Stock
4. Amilpar - Relevant Fact
5. Amilpar - Press Release - Commercial Papers
6. Amilpar - Relevant Fact - Public Offer
7. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
8. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
9. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
10. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
11. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... ... May 30, 2016 , ... Shaolin ... warrior 8-day-8 and 8-night special intensive summer training camp starts on June 17th ... camp offers families and children a fun and unique experience with an opportunity ...
(Date:5/29/2016)... ... May 29, 2016 , ... "With 30 unique self-animating ... user control the style of their project," said Christina Austin - CEO of Pixel ... web-themed intros created exclusively for use in Final Cut Pro X. Pixel Film Studios’ ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 ... and the United Kingdom came together to explore the many pathways individuals use to get ...
(Date:5/27/2016)... ... 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield ... (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields and ... of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and ...
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide ... we as a society can control and change. , As nearly 795,000 Americans suffering ... seconds within the United States. Plus, with an estimated 129,000 of these people dying ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 TARE ... Both Cost Savings and Overall Decreased Use ... BTG), an international specialist healthcare company, has today ... 21st Annual Meeting of ISPOR (International Society for ... hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres is ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
(Date:5/25/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... into a licensing and co-development agreement with Therawis Diagnostics GmbH ... project will be to develop and market PITX2 as a ... and other high-risk breast cancer patients. "We are ...
Breaking Medicine Technology: